Loading provider…
Loading provider…
Medical Oncology Physician in Chicago, IL
NPI: 1437187929Primary Practice Location
NORTHWESTERN LAKE FOREST HOSPITAL
1000 N Westmoreland Rd, Lake Forest, IL
Primary Employer
Northwestern Medical Group
nm.org
HQ Phone
Get MD William's Phone NumberMobile
Get MD William's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 341 | 612 |
| 2 | 96413Infusion of chemotherapy into a vein up to 1 hour | 67 | 304 |
| 3 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 58 | 168 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 52 | 52 |
| 5 | 96375Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 47 | 311 |
Authors: Zaraq Khan, Christos Coutifaris, Lilibeth Torno, Steven Lindheim, Divya Shah, Jodi Skiles, Leena Nahata, Jennifer Mersereau, Lillian Meacham, Jill Ginsberg, Molly Moravek, Pooja Rao, Courtney Finlayson, Wendy Vitek, Veronica Gomez-Lobo, Courtney Marsh, Leonard Sender, William Kutteh, Danny Schust, Jennifer Hirshfeld-Cytron
Journal: Future Oncol
Publication Date: 2018-11-26
Authors: Lidia Schapira, Claudia Perez, Elaine Yu, Alyssa Throckmorton, Swati Kulkarni, Kent Hoskins, Editha Krueger, Della Makower, Shelly Lo
Journal: JCO Oncol Pract
Adjuvant endocrine therapy for early breast cancer: the story so far.
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: Cancer Invest
Lead Sponsor: GlaxoSmithKline
Intervention / Treatment: DRUG: Placebo, DRUG: Fulvestrant, DRUG: GSK525762
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Trastuzumab, DRUG: Pertuzumab, DRUG: Alpelisib, DRUG: Alpelisib matching Placebo
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, DRUG: Docetaxel, OTHER: Quality-of-Life Assessment, DRUG: Atezolizumab, DRUG: Paclitaxel, OTHER: Placebo Administration, PROCEDURE: Computed Tomography, BIOLOGICAL: Trastuzumab, PROCEDURE: Biopsy, PROCEDURE: Bone Scan, BIOLOGICAL: Pertuzumab